Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Perspectives on Wearable Device Data

Posted by Matt Breese on Dec 27, 2017

Find me on:

new-blog-image-science-1.png

In 2018, we will see a rising amount of health-related data generated from personal devices such as smartphones and wearables. One potential application for these tools is to monitor patients in clinical trials remotely.
 
Historically, some concerns with wearable device-derived data have been the lack of regulatory guidance and the difficulty of ensuring data quality.
 
However, in recent years the FDA has shown an increasing commitment to digital health initiatives. In fact, the FDA's Commissioner, Scott Gottlieb, recently released a statement about the importance of encouraging innovation and efficiency in the digital health space.
 

What does the future hold for wearable device-derived health data? According to Debra Michaels, a Senior Scientist at DIA Americas

"It is likely that efforts to reduce barriers to the use of mobile technologies in clinical studies will intensify in the near future. Aside from the potential benefits they may bring to clinical trials, their post-market applications, such as assessment of safety and effectiveness of therapies and improvement of quality of care through data for better patient and shared decision making, are important drivers for adoption of these technologies. The biggest driver of all may be patients, who have embraced mobile technology and expect it to keep improving their lives."

To learn more about the application of wearable derived data in clinical trials, check out Debra Michaels' full piece published by Clinical Leader.   


Subscribe to the MMIT blog for more pharma, provider, and payer perspectives on key topics that affect the healthcare network.

Subscribe for Weekly Perspectives

Topics: Data & Analytics